List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 378 studies with search of:   "Hypercholesterolemia"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Open Label Extension of ISIS 301012 to Treat Familial Hypercholesterolemia
Conditions: Lipid Metabolism, Inborn Errors;   Hypercholesterolemia, Autosomal Dominant;   Hyperlipidemias;   Metabolic Diseases;   Hyperlipoproteinemia Type II;   Metabolism, Inborn Errors;   Genetic Diseases, Inborn;   Infant, Newborn, Diseases;   Metabolic Disorder;   Congenital Abnormalities;   Hypercholesterolemia;   Hyperlipoproteinemias;   Dyslipidemias;   Lipid Metabolism Disorders
Interventions: Drug: mipomersen sodium;   Drug: mipomersen sodium
2 Enrolling by invitation An Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of ISIS 301012 in Subjects With Familial Hypercholesterolemia
Conditions: Lipid Metabolism, Inborn Errors;   Hypercholesterolemia, Autosomal Dominant;   Hyperlipidemias;   Metabolic Diseases;   Hyperlipoproteinemia Type II;   Metabolism, Inborn Errors;   Genetic Diseases, Inborn;   Infant, Newborn, Diseases;   Metabolic Disorder;   Congenital Abnormalities;   Hypercholesterolemia;   Hyperlipoproteinemias;   Dyslipidemias;   Lipid Metabolism Disorders
Intervention: Drug: mipomersen sodium
3 Active, not recruiting Study to Assess the Safety and Efficacy of ISIS 301012 in Homozygous Familial Hypercholesterolemia
Conditions: Lipid Metabolism, Inborn Errors;   Hypercholesterolemia, Autosomal Dominant;   Hyperlipidemias;   Metabolic Diseases;   Hyperlipoproteinemia Type II;   Metabolism, Inborn Errors;   Genetic Diseases, Inborn;   Infant, Newborn, Diseases;   Metabolic Disorder;   Congenital Abnormalities;   Hypercholesterolemia;   Hyperlipoproteinemias;   Dyslipidemias;   Lipid Metabolism Disorders
Interventions: Drug: mipomersen sodium;   Drug: Placebo
4 Enrolling by invitation A 52-Week Post-Marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-Lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05245)
Conditions: Hypercholesterolemia;   Familial Hypercholesterolemia;   Homozygous Sitosterolemia
Interventions: Drug: Ezetimibe;   Drug: Ezetimibe + other lipid-lowering medication(s)
5 Enrolling by invitation A 12-Week Post-Marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-Lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05244)
Conditions: Hypercholesterolemia;   Familial Hypercholesterolemia;   Homozygous Sitosterolemia
Interventions: Drug: Ezetimibe;   Drug: Ezetimibe + other lipid-lowering medication(s)
6 Completed Evaluation of the Safety, Tolerability and Efficacy of Ezetimibe on a Select Population of Filipinos With Hypercholesterolemia (Study P04748)
Conditions: Primary Hypercholesterolemia;   Homozygous Familial Hypercholesterolemia
Intervention: Drug: Ezetimibe
7 Completed Study of Oral MD-0727 Administered to Patients With Primary Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention: Drug: MD-0727
8 Active, not recruiting Long-Term (1 Year) Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
Conditions: Hypercholesterolemia;   Dyslipidemia
Intervention: Drug: Pitavastatin
9 Completed Pan-European Survey on the Under Treatment of Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention:
10 Recruiting Centralized Pan-Asian Survey on the Under Treatment of Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention:
11 Completed Effect of the Plantago Ovata Husk on the Lipid Profile of Patients With Hypercholesterolemia
Conditions: Hypercholesterolemia;   Cardiovascular Disease
Intervention: Drug: Plantago ovata husk
12 Completed An Extension Study of An Investigational Drug in Patients With Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention: Drug: MK0653A, ezetimibe (+) simvastatin / Duration of Treatment: 14 weeks
13 Enrolling by invitation STITCH2 (Simplified Therapeutic Intervention to Control Hypertension and Hypercholesterolemia)
Conditions: Hypertension;   Hypercholesterolemia
Intervention: Other: Treatment algorithm:caduet, Amlodipine, ACEI-ARB combo dose, a-blocker, b-blocker or spironolactone, dyslipidemic therapy with ezetamide
14 Completed A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia
Conditions: Essential Hypertension;   Hypercholesterolemia
Interventions: Drug: simvastatin;   Drug: valsartan
15 Active, not recruiting Evaluation of Efficacy and Safety of AVE5530 in Patients With Primary Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: AVE5530;   Drug: Placebo
16 Completed A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: MK0653A, ezetimibe (+) simvastatin;   Drug: Comparators: simvastatin and ezetimibe
17 Recruiting Evaluation of Safety and Efficacy of AVE5530 as Add-on to Ongoing Statins in Patients With Primary Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: AVE5530;   Drug: AVE5530;   Drug: placebo
18 Active, not recruiting Evaluation of Efficacy and Safety of AVE5530 co-Administered With Atorvastatin in Primary Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: AVE5530;   Drug: atorvastatin;   Drug: placebo
19 Completed Effects of Ezetimibe With Simvastatin in the Therapy of Adolescents With Heterozygous Familial Hypercholesterolemia (Study P02579AM)(COMPLETED)
Condition: Hypercholesterolemia
Intervention: Drug: ezetimibe
20 Completed A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia
Conditions: Hypertension;   Hypercholesterolemia
Intervention: Drug: valsartan + simvastatin

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services